Larvol Delta - Afmed-Receives-FDA-Fast-Track-Designation-for-AFM13-in-Combination-with-AlloNK-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Hodgkin-Lymphoma

AlloNK (AB-101) - GC Biopharma

acimtamig (AFM13) - Affimed

https://www.globenewswire.com/news-release/2023/09/12/2741447/0/en/Affimed-Receives-FDA-Fast-Track-Designation-for-AFM13-in-Combination-with-AlloNK-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Hodgkin-Lymphoma.html

Sep 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next